{
  "id": "5e49ac346d0a27794100000e",
  "type": "factoid",
  "question": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
  "ideal_answer": "PF-05190457 is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27621150"
  ],
  "snippets": [
    {
      "text": "Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27621150",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "PF-05190457"
}